drugset / Trial / NCT00016328
CCI-779 in Treating Patients With Recurrent Glioblastoma Multiforme
NaSingle-groupOpen-labelTreatment
Summary
Phase II trial to study the effectiveness of CCI-779 in treating patients who have recurrent glioblastoma multiforme. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.
Timeline
- Start
- 2001-05
- Primary completion
- 2005-08
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Temsirolimus | Small molecule | — | Intravenous |